Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

Study Overview
=================
Brief Summary
-----------------
Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a platform within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.

Official Title
-----------------
Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

Conditions
-----------------
Covid19, Follow up, Rehabilitation

Intervention / Treatment
-----------------
* Other: quality of live assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: Subject male or female ≥ 18 years old Patient hospitalized in the anesthesia-resuscitation department of the NHC for COVID-19 from March 1, 2020. Patient (or his legal representative) having given his consent for the use of his data for the purposes of this research. exclusion criteria: Subject not hospitalized in intensive care Patient's refusal to participate in the study Inability to give informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.) Subject under low protection

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: quality of live assessment|quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| assess quality of life after severe COVID infection | assess different dimensions of quality of life: physical and mentaland social dimensions | measured at 3 months after ICU left. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Quality of life and Clinical status | Clinical status of patients and assessment of quality of life. collects crucial elements of care based on doctors' prescriptions | measured at 3 and 6 months after ICU left. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
SARS-CoV-2, Follow up, Intensive care unit, Cohort